Leen Ann M. → Marker Therapeutics, Inc. MRKR

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.12

109,110 shares short · -35.4% vs prior

Other 13D/G Filings on Marker Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-08-18	SCHEDULE	New Enterprise Associates 16, L.P.	12.60%	1,625,678	view →
2021-03-26	SC	New Enterprise Associates 16, L.P.	—	—	view →
2020-11-13	SC	Eastern Capital LTD	—	—	view →
2020-02-20	SC	Eastern Capital LTD	—	—	view →
2018-05-16	SC	Eastern Capital LTD	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →